Misinformation on stem cell treatments for COVID-19 linked to overhyped science, researchers argue

The global race to develop new stem cell-based COVID-19 treatments during the pandemic was filled with violations of government regulations, inflated medical claims and distorted public communication, say the authors of a new perspective published Oct. 14 in the journal Stem Cell Reports.
Did you miss our previous article…